Chronic mitochondrial fusion promotor as a novel pharmacological intervention to alleviate left ventricular dysfunction in rats with chronic myocardial infarction

27 August 2022 (14:15 - 14:45)
Organised by:
Congress Presentation Part of: Chronic heart failure - New treatments and trials Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

ESC 365 is supported by

ESC 365 is supported by